Interface Inc TILE

$35.07 -0.57 (-1.60%)

Valuation

Market cap
2,069,115,000
Revenue TTM
$1,386,850,000
Net income TTM
$116,100,000
PE ratio
14.83
Forward PE
15.02
Profit margin
8.37%
Debt to equity
0.30

Trading

Volume
377,900
Avg volume
487,316
Day's range
$34.70 – $35.76
Shares out
58,056,000
Stochastic %K
31%
Beta
1.99
Analysts
Strong Sell
Price target
$38.67

Price

Company profile

Interface, Inc. designs, produces, and sells modular carpet products in the United States, Canada, Latin America, Europe, Africa, Asia, and Australia. The company offers modular carpets; luxury vinyl tiles; modular resilient flooring products; rubber flooring; and carpet tiles used in commercial interiors, include offices, educational facilities, healthcare facilities, airports, hospitality spaces, retail spaces, and...

Show more

Interface, Inc. designs, produces, and sells modular carpet products in the United States, Canada, Latin America, Europe, Africa, Asia, and Australia. The company offers modular carpets; luxury vinyl tiles; modular resilient flooring products; rubber flooring; and carpet tiles used in commercial interiors, include offices, educational facilities, healthcare facilities, airports, hospitality spaces, retail spaces, and residential interiors. It also provides carpet replacement, installation, and maintenance services; and other products and services, including TacTiles carpet tile installation system and adhesives and products for carpet installation and maintenance, as well as project management services. The company sells its products under the Interface, FLOR, NORAPLAN, and NORAMENT brands through direct sales to end users and indirect sales through independent contractors, installers and distributors. Interface, Inc. was incorporated in 1973 and is headquartered in Atlanta, Georgia.

Industry
Furnishings, Fixtures & Appliances
Sector
Consumer Cyclical
Phone
770 437 6800
Website
https://www.interface.com
Address
1280 West Peachtree Street, Atlanta, United States

Latest news

Stocktwits

Prit89 Oct 15, 4:32 PM
$CGC $TILE A small but interesting confirmation: The DEA cites the OLC opinion stating that HHS’s two-part test can be sufficient to establish accepted medical use. This isn’t a new rescheduling decision, but it supports the legal basis behind the process.
0 replies
Primeoptionsst Sep 22, 5:08 PM
🚨 $TILE 40 CALL 10/16 @ .25
0 replies
leifstocks Sep 22, 5:08 PM
$TILE 40 CALL 10/16 @ .25
0 replies
myman1956 Aug 11, 1:17 AM
$TILE Shares that has a sell sigbal on a chart now that could dip at a low of $31.00 with all the data from last week that companies are laying off and not hiring.
0 replies
IN0V8 Aug 10, 6:01 PM
$TILE Barrington Research raises target price to $45 from $36
0 replies
EarningsInsider Aug 7, 1:01 PM
https://www.marketbeat.com/earnings/reports/2026-8-7-interface-inc-stock/ $TILE Interface Earnings Transcript
0 replies
StocktwitsNews Aug 7, 10:55 AM
TILE Q2 2026 Earnings Summary $TILE https://stocktwits.com/news/earnings/earnings/tile-q2-2026-earnings-summary/cZofR71RJBK
0 replies
StocktwitsEarnings Aug 7, 10:42 AM
$TILE Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.89 up 61.82% YoY • Reported revenue of $395.7M up 5.37% YoY • Interface anticipates full fiscal year 2026 net sales of $1.455 to $1.485 billion, with an adjusted gross profit margin of 40.6% and adjusted SG&A expenses of approximately $395 million for Interface.
0 replies